{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:55:26Z","timestamp":1791287726755,"version":"4.3.0"},"reference-count":53,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Thailand Science Research and Innovation Fundamental Fund","award":["180208"],"award-info":[{"award-number":["180208"]}]},{"name":"Thailand Science Research and Innovation Fundamental Fund","award":["2567"],"award-info":[{"award-number":["2567"]}]},{"name":"Thammasat University Research Unit in Molecular Pathogenesis and Immunology of Infectious Disease","award":["180208"],"award-info":[{"award-number":["180208"]}]},{"name":"Thammasat University Research Unit in Molecular Pathogenesis and Immunology of Infectious Disease","award":["2567"],"award-info":[{"award-number":["2567"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>The open-source drug library, namely, MMV Pandemic Response Box, contains 153 antiviral agents, a chemically and pharmacologically diverse mixture of early-stage, emerging anti-infective scaffolds, and mature compounds currently undergoing clinical development. Hence, the Pandemic Response Box might contain compounds that bind and interfere with target molecules or cellular pathways that are conserved or shared among the closely related viruses with enterovirus A71 (EV-A71). This study aimed to screen antiviral agents included in the Pandemic Response Box for repurposing to anti-EV-A71 activity and investigate the inhibitory effects of the compounds on viral replication. The compounds\u2019 cytotoxicity and ability to rescue infected cells were determined by % cell survival using an SRB assay. The hit compounds were verified for anti-EV-A71 activity by virus reduction assays for viral RNA copy numbers, viral protein synthesis, and mature particle production using qRT-PCR, Western blot analysis, and CCID50 assay, respectively. It was found that some of the hit compounds could reduce EV-A71 genome replication and protein synthesis. D-D7 (2-pyridone-containing human rhinovirus 3C protease inhibitor) exhibited the highest anti-EV-A71 activity. Even though D-D7 has been originally indicated as a polyprotein processing inhibitor of human rhinovirus 3C protease, it could be repurposed as an anti-EV-A71 agent.<\/jats:p>","DOI":"10.3390\/ph17060785","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T10:42:34Z","timestamp":1718361754000},"page":"785","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Novel Anti-Enterovirus A71 Compounds Discovered by Repositioning Antivirals from the Open-Source MMV Pandemic Response Box"],"prefix":"10.3390","volume":"17","author":[{"given":"Nattinee","family":"Lochaiyakun","sequence":"first","affiliation":[{"name":"Graduate Program in Biomedical Sciences, Faculty of Allied Health Sciences, Thammasat University, Pathumthani 12120, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Potjanee","family":"Srimanote","sequence":"additional","affiliation":[{"name":"Graduate Program in Biomedical Sciences, Faculty of Allied Health Sciences, Thammasat University, Pathumthani 12120, Thailand"},{"name":"Thammasat University Research Unit in Molecular Pathogenesis and Immunology of Infectious Diseases, Thammasat University, Pathumthani 12120, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onruedee","family":"Khantisitthiporn","sequence":"additional","affiliation":[{"name":"Thammasat University Research Unit in Molecular Pathogenesis and Immunology of Infectious Diseases, Thammasat University, Pathumthani 12120, Thailand"},{"name":"Department of Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Pathumthani 12120, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7238-9591","authenticated-orcid":false,"given":"Jeeraphong","family":"Thanongsaksrikul","sequence":"additional","affiliation":[{"name":"Graduate Program in Biomedical Sciences, Faculty of Allied Health Sciences, Thammasat University, Pathumthani 12120, Thailand"},{"name":"Thammasat University Research Unit in Molecular Pathogenesis and Immunology of Infectious Diseases, Thammasat University, Pathumthani 12120, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Chang, L.Y., Lin, H.Y., Gau, S.S., Lu, C.Y., Hsia, S.H., Huang, Y.C., Huang, L.M., and Lin, T.Y. (2019). Enterovirus A71 Neurologic Complications and Long-term Sequelae. J. Biomed. Sci., 26.","DOI":"10.1186\/s12929-019-0552-7"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e000442","DOI":"10.1136\/bmjgh-2017-000442","article-title":"Severity and Burden of Hand, Foot and Mouth Disease in Asia: A Modelling Study","volume":"3","author":"Koh","year":"2018","journal-title":"BMJ Glob. Health"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/bpa.12279","article-title":"Understanding Enterovirus 71 Neuropathogenesis and Its Impact on Other Neurotropic Enteroviruses","volume":"25","author":"Ong","year":"2015","journal-title":"Brain Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, Epidemiology, Pathogenesis, and Control of Enterovirus 71","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1017\/S0950268818000468","article-title":"Factors Associated with Fatal Outcome of Children with Enterovirus A71 Infection: A Case Series","volume":"146","author":"Yang","year":"2018","journal-title":"Epidemiol. Infect."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Puenpa, J., Wanlapakorn, N., Vongpunsawad, S., and Poovorawan, Y. (2019). The History of Enterovirus A71 Outbreaks and Molecular Epidemiology in The Asia-Pacific Region. J. Biomed. Sci., 26.","DOI":"10.1186\/s12929-019-0573-2"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Zheng, Y., Jit, M., Wu, J.T., Yang, J., Leung, K., Liao, Q., and Yu, H. (2017). Economic Costs and Health-related Quality of Life for Hand, Foot and Mouth Disease (HFMD) Patients in China. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0184266"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e2552","DOI":"10.1093\/cid\/ciaa1853","article-title":"Basic Reproduction Number of Enterovirus 71 and Coxsackievirus A16 and A6: Evidence From Outbreaks of Hand, Foot, and Mouth Disease in China between 2011 and 2018","volume":"73","author":"Zhang","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An Inactivated Enterovirus 71 Vaccine in Healthy Children","volume":"370","author":"Li","year":"2014","journal-title":"New Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/infdis\/jiw502","article-title":"2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study","volume":"215","author":"Wei","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, Safety, and Immunogenicity of An Enterovirus 71 Vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"New Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.apsb.2021.08.017","article-title":"Enterovirus A71 Antivirals: Past, Present, and Future","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jare.2023.03.007","article-title":"Advances in Anti-EV-A71 Drug Development Research","volume":"56","author":"Wang","year":"2024","journal-title":"J. Adv. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.tim.2018.04.004","article-title":"Drug Repurposing for Viral Infectious Diseases: How Far Are We?","volume":"26","author":"Mercorelli","year":"2018","journal-title":"Trends Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"660710","DOI":"10.3389\/fphar.2021.660710","article-title":"Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/acsinfecdis.1c00527","article-title":"The Pandemic Response Box\u2014Accelerating Drug Discovery Efforts after Disease Outbreaks","volume":"8","author":"Samby","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Choi, R., Zhou, M., Shek, R., Wilson, J.W., Tillery, L., Craig, J.K., Salukhe, I.A., Hickson, S.E., Kumar, N., and James, R.M. (2021). High-throughput Screening of the ReFRAME, Pandemic Box, and COVID Box Drug Repurposing Libraries against SARS-CoV-2 Nsp15 Endoribonuclease to Identify Small-molecule Inhibitors of Viral Activity. PLoS ONE, 16.","DOI":"10.1101\/2021.01.21.427657"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"198388","DOI":"10.1016\/j.virusres.2021.198388","article-title":"Discovery of an Imidazonaphthyridine and a Riminophenazine as Potent Anti-Zika Virus Agents Through a Replicon-based High-throughput Screening","volume":"299","author":"Fernandes","year":"2021","journal-title":"Virus Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3748\/wjg.v16.i2.201","article-title":"Rupintrivir is a Promising Candidate for Treating Severe Cases of Enterovirus-71 Infection","volume":"16","author":"Zhang","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1016\/j.molcel.2021.10.003","article-title":"Induced Intra- and Intermolecular Template Switching as a Therapeutic Mechanism against RNA Viruses","volume":"81","author":"Janissen","year":"2021","journal-title":"Mol. Cell."},{"key":"ref_21","unstructured":"(2024, May 26). Pandemic Response Box Supporting Information. Available online: https:\/\/www.mmv.org\/mmv-open\/pandemic-response-box\/pandemic-response-box-supporting-information."},{"key":"ref_22","unstructured":"(2024, May 26). 2D Structure Image of CID 6478675 (2-Pyridone-Containing Peptidomimetics), Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/6478675."},{"key":"ref_23","unstructured":"(2024, May 26). 2D Structure Image of CID 71481097 (Selinexor), Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/71481097."},{"key":"ref_24","unstructured":"(2024, May 26). 2D Structure Image of CID 5271819 (T-1106), Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/5271819."},{"key":"ref_25","unstructured":"(2024, May 26). 2D Structure Image of CID 2782 (Clemizole), Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/2782."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1021\/jm030166l","article-title":"Structure-based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 8. Pharmacological Optimization of Orally Bioavailable 2-Pyridone-containing Peptidomimetics","volume":"46","author":"Dragovich","year":"2003","journal-title":"J. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/14656566.2019.1707184","article-title":"Selinexor for the Treatment of Multiple Myeloma","volume":"21","author":"Podar","year":"2020","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/653080","article-title":"The Hepatitis C Virus (HCV) NS4B RNA Binding Inhibitor Clemizole is Highly Synergistic with HCV Protease Inhibitors","volume":"202","author":"Einav","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_29","unstructured":"(2024, May 26). 2D Structure Image of CID 24780598 (Danirixin), Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/24780598."},{"key":"ref_30","unstructured":"(2024, May 26). 2D Structure Image of CID 1455 (Pocapavir), Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/1455."},{"key":"ref_31","unstructured":"(2024, May 26). 2D Structure Image of CID 65015 (Plerixafor), Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/65015."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"ofz163","DOI":"10.1093\/ofid\/ofz163","article-title":"Co-administered With Standard-of-Care Antiviral (Oseltamivir): A Phase 2b, Global, Randomized Study of Adults Hospitalized with Influenza","volume":"6","author":"Madan","year":"2019","journal-title":"Open Forum Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"105177","DOI":"10.1016\/j.antiviral.2021.105177","article-title":"Comparative Analysis of the Molecular Mechanism of Resistance to Vapendavir across a Panel of Picornavirus Species","volume":"195","author":"Lanko","year":"2021","journal-title":"Antivir. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrd2819","article-title":"Plerixafor","volume":"8","author":"DiPersio","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_35","unstructured":"World Health Organization (2004). Polio Laboratory Manual, World Health Organization. [4th ed.]. Available online: http:\/\/apps.who.int\/iris\/bitstream\/10665\/68762\/1\/WHO_IVB_04.10.pdf."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1021\/jm010469k","article-title":"Structure-based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 6. Structure-activity Studies of Orally Bioavailable, 2-Pyridone-containing Peptidomimetics","volume":"45","author":"Dragovich","year":"2002","journal-title":"J. Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jmb.2011.03.007","article-title":"Crystal Structure of Human Enterovirus 71 3C Protease","volume":"408","author":"Cui","year":"2011","journal-title":"J. Mol. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"8811","DOI":"10.1128\/JVI.00447-11","article-title":"Cleavage of The Adaptor Protein TRIF by Enterovirus 71 3C Inhibits Antiviral Responses Mediated by Toll-like Receptor 3","volume":"85","author":"Lei","year":"2011","journal-title":"J. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"105115","DOI":"10.1016\/j.antiviral.2021.105115","article-title":"Selinexor, a Novel Selective Inhibitor of Nuclear Export, Reduces SARS-CoV-2 Infection and Protects The Respiratory System In Vivo","volume":"192","author":"Kashyap","year":"2021","journal-title":"Antivir. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/s41598-022-05904-6","article-title":"Transcriptome of Human Neuroblastoma SH-SY5Y Cells in Response to 2B Protein of Enterovirus-A71","volume":"12","author":"Suanpan","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_41","first-page":"1","article-title":"Improving Properties of The Nucleobase Analogs T-705\/T-1105 As Potential Antiviral","volume":"57","author":"Jia","year":"2021","journal-title":"Annu. Rep. Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/INF.0000000000000497","article-title":"First Use of Investigational Antiviral Drug Pocapavir (v-073) for Treating Neonatal Enteroviral Sepsis","volume":"34","author":"Myers","year":"2015","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s13365-021-01038-z","article-title":"Compassionate-use Pocapavir and Immunoglobulin Therapy for Treatment of Rituximab-associated Enterovirus Meningoencephalitis","volume":"28","author":"Epstein","year":"2022","journal-title":"J. Neurovirol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/INF.0000000000002584","article-title":"Clearance of Immunodeficiency-associated Vaccine-derived Poliovirus Infection with Pocapavir","volume":"39","author":"Copelyn","year":"2020","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1038\/s41467-023-43029-0","article-title":"A Tradeoff Between Enterovirus A71 Particle Stability and Cell Entry","volume":"14","author":"Catching","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/jmv.21502","article-title":"Enterovirus 71-induced Autophagy Detected In Vitro and In Vivo Promotes Viral Replication","volume":"81","author":"Huang","year":"2009","journal-title":"J. Med. Virol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"FDD77","DOI":"10.4155\/fdd-2022-0007","article-title":"CXCR4 as a Novel Target in Immunology: Moving Away from Typical Antagonists","volume":"4","author":"Caspar","year":"2022","journal-title":"Future Drug Discov."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12950-022-00321-y","article-title":"The Immunological Function of CXCR2 in The Liver During Sepsis","volume":"19","author":"Liu","year":"2022","journal-title":"J. Inflamm."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"22899","DOI":"10.1074\/jbc.M113.449926","article-title":"CXCR4 Chemokine Receptor Signaling Induces Apoptosis in Acute Myeloid Leukemia Cells via Regulation of The Bcl-2 Family Members Bcl-XL, Noxa, and Bak","volume":"288","author":"Kremer","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.virusres.2014.07.026","article-title":"Activation of PI3K\/Akt Pathway Limits JNK-mediated Apoptosis during EV71 Infection","volume":"192","author":"Zhang","year":"2014","journal-title":"Virus Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00705-018-3731-z","article-title":"Identification and Production of Mouse ScFv to Specific Epitope of Enterovirus-71 Virion Protein-2 (VP2)","volume":"163","author":"Thanongsaksrikul","year":"2018","journal-title":"Arch. Virol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B Colorimetric Assay for Cytotoxicity Screening","volume":"1","author":"Vichai","year":"2006","journal-title":"Nat. Protoc."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"12846","DOI":"10.1038\/s41598-022-17272-2","article-title":"Host Neuronal PRSS3 Interacts with Enterovirus A71 3A Protein and Its Role in Viral Replication","volume":"12","author":"Rattanakomol","year":"2022","journal-title":"Sci. Rep."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/6\/785\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:59:02Z","timestamp":1760108342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/6\/785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":53,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["ph17060785"],"URL":"https:\/\/doi.org\/10.3390\/ph17060785","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,14]]}}}